Patent classifications
C
C12
C12N
2770/00
C12N2770/00011
C12N2770/16011
C12N2770/16032
C12N2770/16032
SEQUENTIAL HETEROLOGOUS BOOST ONCOLYTIC VIRAL IMMUNOTHERAPY
20220152168
·
2022-05-19
·
·
The present disclosure relates to a sequential boost oncolytic viral immunotherapy and compositions for use in the same. More particularly, the disclosure relates to oncolytic viruses that significantly increase antigen-specific T cell-mediated immune responses when combined in a sequential heterologous boost treatment regimen.